202-203 / 2001
•
ABS Meeting , 2009
h
i
•
PO 65 : t e PMH exper ence
•
PO 101 : the Seattle experience
•
Both favor Brachytherapy as
•
monotherapy for intermediate-
•
risk patients
•
Seattle ; 9-year BRFS of 91.9 % …
|
|
202-203 / 2001
•
ABS Meeting , 2009
h
i
•
PO 65 : t e PMH exper ence
•
PO 101 : the Seattle experience
•
Both favor Brachytherapy as
•
monotherapy for intermediate-
•
risk patients
•
Seattle ; 9-year BRFS of 91.9 % …